Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

The key to battling the COVID-19 pandemic and its potential aftermath is to develop a variety of vaccines that are efficacious and safe, elicit lasting immunity, and cover a range of SARS-CoV-2 variants. Recombinant viral receptor-binding domains (RBDs) are safe vaccine candidates but often have lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Qibin, Tai, Wanbo, Baxter, Victoria K., Shi, Juan, Wan, Yushun, Zhang, Xiujuan, Montgomery, Stephanie A., Taft-Benz, Sharon A., Anderson, Elizabeth J., Knight, Audrey C., Dinnon, Kenneth H., Leist, Sarah R., Baric, Ralph S., Shang, Jian, Hong, Sung-Wook, Drelich, Aleksandra, Tseng, Chien-Te K., Jenkins, Marc, Heise, Mark, Du, Lanying, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448314/
https://www.ncbi.nlm.nih.gov/pubmed/34492082
http://dx.doi.org/10.1371/journal.ppat.1009897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448314/
https://www.ncbi.nlm.nih.gov/pubmed/34492082
http://dx.doi.org/10.1371/journal.ppat.1009897

Ejemplares similares